Global Interleukin 12 Receptor Market Growth (Status and Outlook) 2022-2028
- LP 4922784
- 60 Pages
- March 2022
- Pharmaceuticals
The United States Interleukin 12 Receptor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Interleukin 12 Receptor market, reaching US$ million by the year 2028. As for the Europe Interleukin 12 Receptor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Interleukin 12 Receptor players cover Eli Lilly and Company, Mallinckrodt Plc, Merck KGaA, and Neumedicines Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Interleukin 12 Receptor market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Edodekin Alfa SR
M-9241
LY-3232094
NMIL-121
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
In-Patient
Out-Patient
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Eli Lilly and Company
Mallinckrodt Plc
Merck KGaA
Neumedicines Inc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interleukin 12 Receptor Market Size 2017-2028
2.1.2 Interleukin 12 Receptor Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Interleukin 12 Receptor Segment by Type
2.2.1 Edodekin Alfa SR
2.2.2 M-9241
2.2.3 LY-3232094
2.2.4 NMIL-121
2.2.5 Others
2.3 Interleukin 12 Receptor Market Size by Type
2.3.1 Interleukin 12 Receptor Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Interleukin 12 Receptor Market Size Market Share by Type (2017-2022)
2.4 Interleukin 12 Receptor Segment by Application
2.4.1 In-Patient
2.4.2 Out-Patient
2.5 Interleukin 12 Receptor Market Size by Application
2.5.1 Interleukin 12 Receptor Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Interleukin 12 Receptor Market Size Market Share by Application (2017-2022)
3 Interleukin 12 Receptor Market Size by Player
3.1 Interleukin 12 Receptor Market Size Market Share by Players
3.1.1 Global Interleukin 12 Receptor Revenue by Players (2020-2022)
3.1.2 Global Interleukin 12 Receptor Revenue Market Share by Players (2020-2022)
3.2 Global Interleukin 12 Receptor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Interleukin 12 Receptor by Regions
4.1 Interleukin 12 Receptor Market Size by Regions (2017-2022)
4.2 Americas Interleukin 12 Receptor Market Size Growth (2017-2022)
4.3 APAC Interleukin 12 Receptor Market Size Growth (2017-2022)
4.4 Europe Interleukin 12 Receptor Market Size Growth (2017-2022)
4.5 Middle East & Africa Interleukin 12 Receptor Market Size Growth (2017-2022)
5 Americas
5.1 Americas Interleukin 12 Receptor Market Size by Country (2017-2022)
5.2 Americas Interleukin 12 Receptor Market Size by Type (2017-2022)
5.3 Americas Interleukin 12 Receptor Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interleukin 12 Receptor Market Size by Region (2017-2022)
6.2 APAC Interleukin 12 Receptor Market Size by Type (2017-2022)
6.3 APAC Interleukin 12 Receptor Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Interleukin 12 Receptor by Country (2017-2022)
7.2 Europe Interleukin 12 Receptor Market Size by Type (2017-2022)
7.3 Europe Interleukin 12 Receptor Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interleukin 12 Receptor by Region (2017-2022)
8.2 Middle East & Africa Interleukin 12 Receptor Market Size by Type (2017-2022)
8.3 Middle East & Africa Interleukin 12 Receptor Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Interleukin 12 Receptor Market Forecast
10.1 Global Interleukin 12 Receptor Forecast by Regions (2023-2028)
10.1.1 Global Interleukin 12 Receptor Forecast by Regions (2023-2028)
10.1.2 Americas Interleukin 12 Receptor Forecast
10.1.3 APAC Interleukin 12 Receptor Forecast
10.1.4 Europe Interleukin 12 Receptor Forecast
10.1.5 Middle East & Africa Interleukin 12 Receptor Forecast
10.2 Americas Interleukin 12 Receptor Forecast by Country (2023-2028)
10.2.1 United States Interleukin 12 Receptor Market Forecast
10.2.2 Canada Interleukin 12 Receptor Market Forecast
10.2.3 Mexico Interleukin 12 Receptor Market Forecast
10.2.4 Brazil Interleukin 12 Receptor Market Forecast
10.3 APAC Interleukin 12 Receptor Forecast by Region (2023-2028)
10.3.1 China Interleukin 12 Receptor Market Forecast
10.3.2 Japan Interleukin 12 Receptor Market Forecast
10.3.3 Korea Interleukin 12 Receptor Market Forecast
10.3.4 Southeast Asia Interleukin 12 Receptor Market Forecast
10.3.5 India Interleukin 12 Receptor Market Forecast
10.3.6 Australia Interleukin 12 Receptor Market Forecast
10.4 Europe Interleukin 12 Receptor Forecast by Country (2023-2028)
10.4.1 Germany Interleukin 12 Receptor Market Forecast
10.4.2 France Interleukin 12 Receptor Market Forecast
10.4.3 UK Interleukin 12 Receptor Market Forecast
10.4.4 Italy Interleukin 12 Receptor Market Forecast
10.4.5 Russia Interleukin 12 Receptor Market Forecast
10.5 Middle East & Africa Interleukin 12 Receptor Forecast by Region (2023-2028)
10.5.1 Egypt Interleukin 12 Receptor Market Forecast
10.5.2 South Africa Interleukin 12 Receptor Market Forecast
10.5.3 Israel Interleukin 12 Receptor Market Forecast
10.5.4 Turkey Interleukin 12 Receptor Market Forecast
10.5.5 GCC Countries Interleukin 12 Receptor Market Forecast
10.6 Global Interleukin 12 Receptor Forecast by Type (2023-2028)
10.7 Global Interleukin 12 Receptor Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Information
11.1.2 Eli Lilly and Company Interleukin 12 Receptor Product Offered
11.1.3 Eli Lilly and Company Interleukin 12 Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Eli Lilly and Company Main Business Overview
11.1.5 Eli Lilly and Company Latest Developments
11.2 Mallinckrodt Plc
11.2.1 Mallinckrodt Plc Company Information
11.2.2 Mallinckrodt Plc Interleukin 12 Receptor Product Offered
11.2.3 Mallinckrodt Plc Interleukin 12 Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Mallinckrodt Plc Main Business Overview
11.2.5 Mallinckrodt Plc Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Interleukin 12 Receptor Product Offered
11.3.3 Merck KGaA Interleukin 12 Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Neumedicines Inc
11.4.1 Neumedicines Inc Company Information
11.4.2 Neumedicines Inc Interleukin 12 Receptor Product Offered
11.4.3 Neumedicines Inc Interleukin 12 Receptor Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Neumedicines Inc Main Business Overview
11.4.5 Neumedicines Inc Latest Developments
12 Research Findings and Conclusion
Table 1. Interleukin 12 Receptor Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Edodekin Alfa SR
Table 3. Major Players of M-9241
Table 4. Major Players of LY-3232094
Table 5. Major Players of NMIL-121
Table 6. Major Players of Others
Table 7. Interleukin 12 Receptor Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Interleukin 12 Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Interleukin 12 Receptor Market Size Market Share by Type (2017-2022)
Table 10. Interleukin 12 Receptor Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Interleukin 12 Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Interleukin 12 Receptor Market Size Market Share by Application (2017-2022)
Table 13. Global Interleukin 12 Receptor Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Interleukin 12 Receptor Revenue Market Share by Player (2020-2022)
Table 15. Interleukin 12 Receptor Key Players Head office and Products Offered
Table 16. Interleukin 12 Receptor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Interleukin 12 Receptor Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Interleukin 12 Receptor Market Size Market Share by Regions (2017-2022)
Table 21. Americas Interleukin 12 Receptor Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Interleukin 12 Receptor Market Size Market Share by Country (2017-2022)
Table 23. Americas Interleukin 12 Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Interleukin 12 Receptor Market Size Market Share by Type (2017-2022)
Table 25. Americas Interleukin 12 Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Interleukin 12 Receptor Market Size Market Share by Application (2017-2022)
Table 27. APAC Interleukin 12 Receptor Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Interleukin 12 Receptor Market Size Market Share by Region (2017-2022)
Table 29. APAC Interleukin 12 Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Interleukin 12 Receptor Market Size Market Share by Type (2017-2022)
Table 31. APAC Interleukin 12 Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Interleukin 12 Receptor Market Size Market Share by Application (2017-2022)
Table 33. Europe Interleukin 12 Receptor Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Interleukin 12 Receptor Market Size Market Share by Country (2017-2022)
Table 35. Europe Interleukin 12 Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Interleukin 12 Receptor Market Size Market Share by Type (2017-2022)
Table 37. Europe Interleukin 12 Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Interleukin 12 Receptor Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Interleukin 12 Receptor Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Interleukin 12 Receptor Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Interleukin 12 Receptor Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Interleukin 12 Receptor Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Interleukin 12 Receptor Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Interleukin 12 Receptor Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Interleukin 12 Receptor
Table 46. Key Market Challenges & Risks of Interleukin 12 Receptor
Table 47. Key Industry Trends of Interleukin 12 Receptor
Table 48. Global Interleukin 12 Receptor Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Interleukin 12 Receptor Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Interleukin 12 Receptor Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Interleukin 12 Receptor Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Interleukin 12 Receptor Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Interleukin 12 Receptor Market Size Market Share Forecast by Application (2023-2028)
Table 54. Eli Lilly and Company Details, Company Type, Interleukin 12 Receptor Area Served and Its Competitors
Table 55. Eli Lilly and Company Interleukin 12 Receptor Product Offered
Table 56. Eli Lilly and Company Interleukin 12 Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Eli Lilly and Company Main Business
Table 58. Eli Lilly and Company Latest Developments
Table 59. Mallinckrodt Plc Details, Company Type, Interleukin 12 Receptor Area Served and Its Competitors
Table 60. Mallinckrodt Plc Interleukin 12 Receptor Product Offered
Table 61. Mallinckrodt Plc Main Business
Table 62. Mallinckrodt Plc Interleukin 12 Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Mallinckrodt Plc Latest Developments
Table 64. Merck KGaA Details, Company Type, Interleukin 12 Receptor Area Served and Its Competitors
Table 65. Merck KGaA Interleukin 12 Receptor Product Offered
Table 66. Merck KGaA Main Business
Table 67. Merck KGaA Interleukin 12 Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Merck KGaA Latest Developments
Table 69. Neumedicines Inc Details, Company Type, Interleukin 12 Receptor Area Served and Its Competitors
Table 70. Neumedicines Inc Interleukin 12 Receptor Product Offered
Table 71. Neumedicines Inc Main Business
Table 72. Neumedicines Inc Interleukin 12 Receptor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Neumedicines Inc Latest Developments
List of Figures
Figure 1. Interleukin 12 Receptor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Interleukin 12 Receptor Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Interleukin 12 Receptor Market Size Market Share by Type in 2021
Figure 7. Interleukin 12 Receptor in In-Patient
Figure 8. Global Interleukin 12 Receptor Market: In-Patient (2017-2022) & ($ Millions)
Figure 9. Interleukin 12 Receptor in Out-Patient
Figure 10. Global Interleukin 12 Receptor Market: Out-Patient (2017-2022) & ($ Millions)
Figure 11. Global Interleukin 12 Receptor Market Size Market Share by Application in 2021
Figure 12. Global Interleukin 12 Receptor Revenue Market Share by Player in 2021
Figure 13. Global Interleukin 12 Receptor Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Interleukin 12 Receptor Market Size 2017-2022 ($ Millions)
Figure 15. APAC Interleukin 12 Receptor Market Size 2017-2022 ($ Millions)
Figure 16. Europe Interleukin 12 Receptor Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Interleukin 12 Receptor Market Size 2017-2022 ($ Millions)
Figure 18. Americas Interleukin 12 Receptor Value Market Share by Country in 2021
Figure 19. Americas Interleukin 12 Receptor Consumption Market Share by Type in 2021
Figure 20. Americas Interleukin 12 Receptor Market Size Market Share by Application in 2021
Figure 21. United States Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Interleukin 12 Receptor Market Size Market Share by Region in 2021
Figure 26. APAC Interleukin 12 Receptor Market Size Market Share by Application in 2021
Figure 27. China Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Interleukin 12 Receptor Market Size Market Share by Country in 2021
Figure 34. Europe Interleukin 12 Receptor Market Size Market Share by Type in 2021
Figure 35. Europe Interleukin 12 Receptor Market Size Market Share by Application in 2021
Figure 36. Germany Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Interleukin 12 Receptor Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Interleukin 12 Receptor Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Interleukin 12 Receptor Market Size Market Share by Application in 2021
Figure 44. Egypt Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Interleukin 12 Receptor Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 50. APAC Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 51. Europe Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 53. United States Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 54. Canada Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 57. China Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 58. Japan Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 59. Korea Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 61. India Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 62. Australia Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 63. Germany Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 64. France Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 65. UK Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 66. Italy Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 67. Russia Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 68. Spain Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 71. Israel Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Interleukin 12 Receptor Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
